• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

Introduction to 2-(1-(3-chlorophenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS No. 1138077-59-4)

2-(1-(3-chlorophenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, identified by its CAS number 1138077-59-4, is a specialized organoboron compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This compound belongs to the class of boron-containing heterocycles, which are widely recognized for their utility in cross-coupling reactions, particularly in the Suzuki-Miyaura coupling process. The unique structural features of this molecule, including its tetramethyl-substituted dioxaborolane core and a 3-chlorophenyl ethyl side chain, make it a valuable intermediate in the synthesis of complex organic molecules.

The dioxaborolane moiety is a key functional group that facilitates boron-carbon bond formation under palladium-catalyzed conditions. This property is particularly advantageous in pharmaceutical applications where precise carbon-carbon bond construction is essential for drug development. The presence of the 3-chlorophenyl ethyl group further enhances the reactivity and selectivity of the compound, making it a versatile building block for medicinal chemists.

In recent years, there has been a surge in research focused on developing novel boron-containing compounds for therapeutic purposes. Boronated heterocycles have shown promise in various areas, including anticancer agents and anti-inflammatory drugs. The tetramethyl substitution on the dioxaborolane ring not only stabilizes the boron center but also influences the electronic properties of the molecule, which can be fine-tuned to achieve desired biological activities.

One of the most compelling aspects of 2-(1-(3-chlorophenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is its potential application in the synthesis of small-molecule inhibitors targeting specific biological pathways. For instance, studies have demonstrated its utility in generating novel kinase inhibitors by serving as a precursor for constructing complex aryl-alkyl scaffolds. These inhibitors are critical in treating diseases such as cancer and inflammatory disorders.

The pharmaceutical industry has increasingly relied on organoboron compounds due to their ability to undergo efficient cross-coupling reactions under mild conditions. This characteristic reduces the need for harsh reagents and high temperatures, thereby improving overall reaction yields and scalability. The Suzuki-Miyaura coupling, in particular, has become a cornerstone technique in drug discovery, allowing for the rapid assembly of biaryl structures that are prevalent in many active pharmaceutical ingredients (APIs).

Recent advancements in synthetic methodologies have further expanded the applications of dioxaborolanes. Researchers have developed innovative approaches to functionalize these compounds at multiple positions, enabling the creation of highly diverse molecular libraries. Such libraries are invaluable for high-throughput screening (HTS) campaigns aimed at identifying lead compounds with desired pharmacological properties.

The 3-chlorophenyl ethyl group in 2-(1-(3-chlorophenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane provides an additional handle for further derivatization. Chloro substituents are commonly used in medicinal chemistry due to their ease of removal or transformation into other functional groups such as amines or alcohols. This flexibility allows chemists to explore different chemical space rapidly and efficiently.

From a mechanistic perspective, the reactivity of this compound can be attributed to the stability provided by the tetramethyl environment around the boron atom. This stability ensures that the boron center remains accessible for cross-coupling reactions without undergoing unwanted side reactions. Additionally, the electronic nature of the 3-chlorophenyl ethyl side chain influences how it interacts with transition metals during catalysis.

In conclusion,2-(1-(3-chlorophenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS No. 1138077-59-4) represents a significant advancement in synthetic organic chemistry with broad implications for drug discovery and development. Its unique structural features make it an indispensable tool for medicinal chemists seeking to design novel therapeutics targeting complex diseases. As research continues to uncover new applications for boron-containing compounds,this molecule is poised to play an increasingly important role in future pharmaceutical innovations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)